BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37898768)

  • 1. Application of non-invasive prenatal testing in screening chromosomal aberrations in pregnancies with different nuchal translucency cutoffs.
    Xu Y; Hu S; Chen L; Hao Y; Zhang H; Xu Z; Wu W; Deng L
    Mol Cytogenet; 2023 Oct; 16(1):29. PubMed ID: 37898768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.
    Petersen OB; Smith E; Van Opstal D; Polak M; Knapen MFCM; Diderich KEM; Bilardo CM; Arends LR; Vogel I; Srebniak MI
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):765-774. PubMed ID: 32306377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
    Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
    Arch Gynecol Obstet; 2024 Apr; ():. PubMed ID: 38625542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide data on prenatal profiles and detection compared with NIPT.
    Gadsbøll K; Vogel I; Kristensen SE; Pedersen LH; Hyett J; ; Petersen OB
    Ultrasound Obstet Gynecol; 2024 Apr; ():. PubMed ID: 38642365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of expanded noninvasive prenatal test in prenatal diagnosis of fetuses with increased nuchal translucency.
    Xie X; Zhou H; Zhao Q; Lu Y; Meng Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6213-6218. PubMed ID: 34649482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency.
    Wang C; Tang J; Tong K; Huang D; Tu H; Zhu J
    J Hum Genet; 2022 Sep; 67(9):533-539. PubMed ID: 35578003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.
    Srebniak MI; de Wit MC; Diderich KE; Govaerts LC; Joosten M; Knapen MF; Bos MJ; Looye-Bruinsma GA; Koningen M; Go AT; Galjaard RJ; Van Opstal D
    Mol Cytogenet; 2016; 9(1):69. PubMed ID: 27610202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age.
    Su JY; Wei YN; Chen HF; Tong JR; Chen Y; Deng L; Huang LL; Zhang LY
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7101-7106. PubMed ID: 37606120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased use of diagnostic testing after increased nuchal translucency: The influence of non-invasive prenatal testing and chromosomal microarray.
    Bunnell ME; Adams S; Pelletier A; Hoffman Sage Y
    Prenat Diagn; 2022 Dec; 42(13):1606-1611. PubMed ID: 36314137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
    Maxwell S; Dickinson JE; Murch A; O'Leary P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency.
    Cicatiello R; Pignataro P; Izzo A; Mollo N; Pezone L; Maruotti GM; Sarno L; Sglavo G; Conti A; Genesio R; Nitsch L
    Med Sci (Basel); 2019 Feb; 7(3):. PubMed ID: 30818867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35.
    Huang J; Wu D; He JH; Wang JY; Li X; Wang ZY; Wang Y; Liu HY
    Front Med (Lausanne); 2024; 11():1376319. PubMed ID: 38633307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the application of non-invasive prenatal testing in the detection of foetal chromosomal copy number variations.
    Wang C; Tang J; Tong K; Huang D; Tu H; Li Q; Zhu J
    BMC Med Genomics; 2021 Dec; 14(1):292. PubMed ID: 34895207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program.
    Vogel I; Petersen OB; Christensen R; Hyett J; Lou S; Vestergaard EM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):480-486. PubMed ID: 28608362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cut-off value of nuchal translucency as indication for chromosomal microarray analysis.
    Maya I; Yacobson S; Kahana S; Yeshaya J; Tenne T; Agmon-Fishman I; Cohen-Vig L; Shohat M; Basel-Vanagaite L; Sharony R
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):332-335. PubMed ID: 28133835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of positive CNVs results by NIPT without fetal ultrasonography-identified structural anomalies.
    Wang C; Mei L; Wan Y; Li H; Luan S; Lu J; Wang P; Wen L; Han X; Li X; Zhang N
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2352. PubMed ID: 38284447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal testing, ultrasonographic findings and poor prenatal diagnosis rates for twin pregnancies: a retrospective study.
    Yuan X; Wang W; Dai L; Yong W; Pei C; Li J; Wu L
    BMC Pregnancy Childbirth; 2023 May; 23(1):351. PubMed ID: 37179315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array study in fetuses with nuchal translucency above the 95th percentile: a 4-year observational single-centre study.
    Coello-Cahuao E; Sánchez-Durán MÁ; Calero I; Higueras MT; García MA; Rodó C; Maiz N; Plaja Rustein A; Castells-Sarret N; Mediano-Vizuete C; Carreras E
    Arch Gynecol Obstet; 2023 Jan; 307(1):285-292. PubMed ID: 35486155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.